Dr. Reddy's Labs Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 28, 2025 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
TL;DR
Dr. Reddy's Labs filed a standard 6-K, no major news here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 28, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations company and will file its annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is adhering to its reporting obligations as a foreign private issuer, which is standard for companies listed on US exchanges but based internationally.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information or financial disclosures.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-25-000728 (filing_id) — Accession Number
- 20251128 (date) — Filing Date
- 2834 (sic_code) — Standard Industrial Classification
- Hyderabad, India (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating routine reporting by Dr. Reddy's Laboratories Ltd.
When was this Form 6-K filed?
The filing was made on November 28, 2025.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
The company's principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Under which form will Dr. Reddy's Laboratories Ltd. file its annual reports?
Dr. Reddy's Laboratories Ltd. will file its annual reports under cover of Form 20-F.
What is the Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd. listed in this filing?
The SIC code listed is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 400 words · 2 min read · ~1 pages · Grade level 16.4 · Accepted 2025-11-26 21:26:24
Filing Documents
- rdy0824_6k.htm (6-K) — 51KB
- rdy0824_ex99-1.htm (EX-99.1) — 30KB
- rdy0824_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0824_ex99-1img02.jpg (GRAPHIC) — 8KB
- 0001575872-25-000728.txt ( ) — 107KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: November 24, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3